ME/CFS specialists generally recommend comparatively lower doses than standard followed by gradual titration, colloquially referred to as the start low, go slow strategy
Another human sleep-wake study reported improved daytime alertness or performance, but sample size was not clearly reported and it was not an exercise-recovery trial [6]
In the past years, muramidase has been shown to be effective in hydrolyzing peptidoglycan fragments, especially at small-intestine level in broilers, and to improve digestibility and performance
There have been no randomized controlled trials of this medication in women with lipedema
Below is a framework comparing theoretical transfer risk factors for common GLP-1 medications based on known pharmacokinetics and analogous drug classes
Starting patients on a lower dose led to fewer side effects on average